Concepedia

Ling Lu

LL

Statistics

Publications

39

Citations

2.3K

H-Index

24

Active since

1998

Affiliations

Cornell University(Current)

Beijing University of Chemical Technology

Chinese Academy of Medical Sciences & Peking Union Medical College

Center for Excellence in Molecular Cell Science

Tongji University

Ling Lu is an author at Cornell University specializing in medicine, oncology, and molecular oncology.

Publications per year

1998–2025

39

Publications

39

Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro

Keith Dredge, Rebecca Horsfall, Simon P. Robinson et al. · Microvascular Research · 2005 · 268 citations

Medicine, Oncology, Pharmacology +13

The anti-cancer drug lenalidomide inhibits angiogenesis and metastasis via multiple inhibitory effects on endothelial cell function in normoxic and hypoxic conditions

Ling Lu, Faribourz Payvandi, Lei Wu et al. · Microvascular Research · 2008 · 224 citations

Medicine, Oncology, Pharmacology +17

Rate of CRL4CRBN substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4

Chad C. Bjorklund, Ling Lu, Jian Kang et al. · Blood Cancer Journal · 2015 · 217 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

Collagen microarchitecture mechanically controls myofibroblast differentiation

Bo Ri Seo, Xingyu Chen, Ling Lu et al. · Proceedings of the National Academy of Sciences · 2020 · 201 citations · Full text

Engineering, Bioengineering, Biomedical Engineering +17

Loss of Sirtuin 1 Alters the Secretome of Breast Cancer Cells by Impairing Lysosomal Integrity

Arash Latifkar, Ling Lu, Amrit Hingorani et al. · Developmental Cell · 2019 · 152 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +16

1–5 of 39